@RestelliniS

Gastroenterologist, Director of the Crohn and Colitis Center of Geneva, Adjunct professor at McGill University Health Center, IBDnet, ECCO, EduCom

Joined April 2019
  • Tweets239
  • Following217
  • Followers502
44Media
💜 May 19 – World IBD Day The Geneva Crohn & Colitis Center reaffirms its commitment to patients living with IBD. Like pieces of a puzzle, every patient, caregiver, healthcare professional, and scientific advance helps move IBD care forward. #WorldIBDDay #IBD #Hopital de la Tour
3
8
206
Looking forward to welcoming you to Paris with Paul McLellan 🇫🇷 #IBUS #BowelUltrasound #MedicalEducation #Paris #IBD #Gastroenterology @HopitaldeLaTour
InternationalBowelUS@BowelUltrasoundApr 21
We’re excited to share a message from Dr. Sophie Restellini (Switzerland) and from Dr. Paul McLellan (France), organizers of our upcoming IBUS Hybrid Module 1 and IBUSXP Masterclass workshops in Paris, France 👏 📅 November 26th - 27th, 2026 ⏳ Deadline on June 11th!
1
8
322
Sophie Restellini retweeted
InternationalBowelUS@BowelUltrasoundApr 21
We’re excited to share a message from Dr. Sophie Restellini (Switzerland) and from Dr. Paul McLellan (France), organizers of our upcoming IBUS Hybrid Module 1 and IBUSXP Masterclass workshops in Paris, France 👏 📅 November 26th - 27th, 2026 ⏳ Deadline on June 11th!
2
1
11
790
Looking forward to insightful discussions at the IBDSA Visiting Professorship in Adelaide 🇦🇺 See you there! Thank you Patricia Kaazan! #ibd #crohn #colitis #pregnancy IBDSA #Crohn's colitis care Hôpital de La Tour
Patriciakaazan@KaazanPatriciaApr 18
I am incredibly excited to be hosting @RestelliniS at the “IBDSA visiting professorship”. She will be discussing pregnancy in IBD updates with our IBD doctors & obstetric physicians! #meded #ibd #crohns #colitis #pregnancy
5
290
Sophie Restellini retweeted
Patriciakaazan@KaazanPatriciaApr 18
I am incredibly excited to be hosting @RestelliniS at the “IBDSA visiting professorship”. She will be discussing pregnancy in IBD updates with our IBD doctors & obstetric physicians! #meded #ibd #crohns #colitis #pregnancy
2
1
12
909
New publication in #JCCPlus 📚 Innovative educational strategies in #IBD - from case-based learning to simulation and gamified microlearning - may better prepare clinicians and improve patient care. Glad to have contributed with amazing colleagues from the @ECCO_IBD Education Committee. #MedicalEducation #ECCO #Gastroenterology #JCCPlus
1
8
1
28
3,293
Excited to join the ECCO e-Learning Editorial Team as e-Learning Content Lead! 📚 Looking forward to contributing to IBD education and working with such a fantastic team. 🤝 #ECCO #IBD #MedEd
4
26
1,061
Sophie Restellini retweeted
Fabi An E. Puentes M.@puentesfabiMar 5
Felicitaciones a @Bealoquebea y @manu_barreiro 🇪🇸 por su nueva asignación en #ECCO @geteccu @pancco_org
3
9
22
1,104
Honored to speak at the “IBDSA Visiting Professorship”. Looking forward to discussing pregnancy in IBD with IBD & obstetric colleagues — multidisciplinary collaboration is key. Thanks to ⁦@KaazanPatricia⁩! #IBD #PregnancyInIBD linkedin.com/posts/ibdsa-cro…

We are pleased to announce that Prof Sophie Restellini will be our guest speaker for the "IBDSA...

We are pleased to announce that Prof Sophie Restellini will be our guest speaker for the "IBDSA visiting professorship" meeting. PD Dr med. Sophie Restellini. She will be discussing pregnancy in IBD...

linkedin.com
4
10
451
Back from #ECCO26 in Stockholm 🇸🇪 Proud to serve on EduCom with a STELAR team 🤝 The Advanced IBD Course was a great success — Postgraduate Course coming soon 🔜 Fantastic meeting on holistic IBD care 🧡 + first JCC Plus Editorial Board. Grateful for inspiring colleagues 🙏🏻 #ECCO26 #IBD #MedicalEducation #JCCPlus
4
1
28
1,558
Sophie Restellini retweeted
Anuraag Jena@DrAnuraagJFeb 19
Most important slide of long term outcomes of Profile study by Dr Noor #ECCO2026
3
31
985
Sophie Restellini retweeted
Patriciakaazan@KaazanPatricia7 Dec 2025
Inaugural “visiting IBDSA professorship” with @DCharabaty . Aline joined us from Washington at 4:00 am to discuss IL23’s in IBD! A full house of gastroenterologists, colorectal surgeons & IBD allied health. Great discussions & excellent feedback !Looking forward to host @RestelliniS soon
1
6
2
18
3,221
Sophie Restellini retweeted
Uma Mahadevan@UmaMahadevanIBD27 Oct 2025
More confirmation of risk of preeclampsia in IBD pregnancy. Remember to give low dose aspirin starting week 12 as recommended in the Global Consensus! @MLongMD @LindsayClarkeMD @JulsgaardMette pubmed.ncbi.nlm.nih.gov/4112…

The Risk of Hypertensive Disorders of Pregnancy in Inflammatory Bowel Disease - PubMed

Although the risk of hypertensive disorders of pregnancy overall was not increased in pregnancies affected by IBD, there was an increased risk of pre-eclampsia. This may reflect underlying immune-m...

pubmed.ncbi.nlm.nih.gov
15
3
34
9,316
Therapeutic B-cell targeting: the next big thing in #IBD treatment for selected pts? @RajaAtreya #MarkusNeurath 🌍✨ #Crohns #Colitis #MedTwitter @IBD_FloMD @fgomollon @Y_ECCO_IBD @ibddoctor @IBDMD @DignassAxel @RestelliniS nejm.org/doi/full/10.1056/NE…

CD19 CAR T-Cell Therapy in Multidrug-Resistant Ulcerative Colitis | NEJM

In a patient with treatment-resistant ulcerative colitis, CD19 CAR T-cell therapy led to drug-free remission and mucosal healing, suggesting that B-cell targeting may offer a novel therapeutic ...

nejm.org
15
1
33
3,460
Sophie Restellini retweeted
Beatriz Gros
@Bealoquebea29 Aug 2025
Positioning thiopurines in IBD in 2025 Nice talk for a difficult topic by @RestelliniS at @IBDnet
1
38
1
122
9,351
Sophie Restellini retweeted
Joana Torres@JoanaTo6252300419 Aug 2025
Are IBD patients & their families ready for prediction + prevention? ✅ Yes! Time for the IBD community to unite & make it happen. doi.org/10.1002/ueg2.70091

Patient and First‐Degree Relatives Perceptions About Prediction and Prevention of Inflammatory...

Background and Objective While significant advances have been made in identifying biomarkers for predicting inflammatory bowel disease (IBD) onset, little is known about the willingness of at-risk...

onlinelibrary.wiley.com
26
4
73
6,426
Sophie Restellini retweeted
IBDJournal & CC360@IBDJournals17 Jul 2025
What are the risk factors for unplanned 🤰in women with IBD? 🧐 Data from PIANO 🎹 showed ⬆️ risk in women who: ➡️ Face 💰and educational barriers ⛔️ ➡️ Do not have a domestic partner ➡️ Belong to minority groups @EJBrenner_MD @UmaMahadevanIBD @MLongMD doi.org/10.1093/ibd/izaf046

Risk Factors for Contraceptive Failure and Unintended Pregnancy Among Women With Inflammatory Bowel...

Lay Summary. Among pregnant women with IBD, risk factors for unplanned pregnancy from contraceptive failure included low socioeconomic status, low educatio

academic.oup.com
14
24
1,617
Sophie Restellini retweeted
Mette Julsgaard@JulsgaardMette14 Jul 2025
🚨Nationwide 🇩🇰study challenges the belief that laparoscopic #IPAA is safer for fertility than open #IPAA in women with #UC - no difference in birth rates or other fertility meassures. Important when counselling women with UC. @AUHdk @HepGas @OUHhospital pubmed.ncbi.nlm.nih.gov/4064…

Birth rates after laparoscopic and open ileal pouch-anal anastomosis for ulcerative colitis: a...

Birth rates after laparoscopic and open ileal pouch-anal anastomosis for ulcerative colitis: a nationwide population-based cohort study

pubmed.ncbi.nlm.nih.gov
8
1
25
3,269
Sophie Restellini retweeted
Mette Julsgaard@JulsgaardMette2 Jul 2025
🤱#Upadacitinib detectable in breast milk(n=40) Relative Infant Dose 2.7% (IQR 0.8-10.6) RID ~ #tofacitinib but ⬆️ than other #IBD drugs. ⚠️with high GI bioavailability & unknown 👶🏼immune effects, avoid breastfeeding. Great collaboration 🇧🇪🇨🇿🇩🇪🇺🇸🇩🇰@AGA_CGH pubmed.ncbi.nlm.nih.gov/4057…

Upadacitinib in Mothers With Inflammatory Bowel Disease: Placental Transfer and Breast Milk...

Upadacitinib in Mothers With Inflammatory Bowel Disease: Placental Transfer and Breast Milk Excretion

pubmed.ncbi.nlm.nih.gov
2
22
2
54
3,999
Load more